1,4-Dioxane hydrochloride → HCID 118023049, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]([C:12]2[CH:13]=[N:14][C:15]([N:18]3[CH2:23][CH2:22][N:21](C(OC(C)(C)C)=O)[CH2:20][CH2:19]3)=[N:16][CH:17]=2)([CH3:11])[CH2:9][OH:10])=[CH:4][CH:3]=1.Cl.O1CCOCC1>C(Cl)Cl>[F:1][C:2]1[CH:7]=[CH:6][C:5]([C@@:8]([C:12]2[CH:13]=[N:14][C:15]([N:18]3[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]3)=[N:16][CH:17]=2)([CH3:11])[CH2:9][OH:10])=[CH:4][CH:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a mixture of tert-butyl 4-(5-(2-(4-fluorophenyl)-1-hydroxypropan-2-yl)pyrimidin-2-yl)piperazine-1-carboxylate (450 mg, 1.08 mmol) in DCM (20 mL) was added 4 M HCl/1,4-dioxane (3 mL). After stirred at RT for 15 h, the reaction mixture was concentrated, the residue was diluted by aq. NaHCO3 (20 mL) and extracted with DCM. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered and concentrated. The residue was separated by chiral Prep-HPLC to give (R)-2-(4-fluorophenyl)-2-(2-(piperazin-1-yl)pyrimidin-5-yl)propan-1-ol (100 mg, 29%) as a white solid. MS (ES+) C17H21FN4O requires: 316. found: 317 [M+H]+. Chiral HPLC, Column: IC 4.6*150 mm 5 um, Co-Solvent: EtOH:Hexane=1:1 (0.1% DEA), RT=4.22 min.
Workup
- concentrationthe reaction mixture was concentrated
- additionthe residue was diluted by aq. NaHCO3 (20 mL)
- extractionextracted with DCM
- washThe combined organic layers were washed with water and brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated
- customThe residue was separated by chiral Prep-HPLC
Sources & evidence
- ORD record
- ord-de822071537345c6a075fc68c2f9b568
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09200002B2
Reaction notes
Loading…